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Background: Left-stellate ganglion stimulation (LSGS) can modify regional dispersion of ventricular refractori-
ness, promote triggered activity, and reduce the threshold for ventricular ﬁbrillation (VF). Sympathetic hyperac-
tivity precipitates torsades de pointes (TdP) andVF in susceptible patientswith long-QT syndrome type 1 (LQT1).
We investigated the electromechanical effects of LSGS in a caninemodel of drug-induced LQT1, gaining novel ar-
rhythmogenic insights.
Methods: In nine mongrel dogs, the left and right stellate ganglia were exposed for electrical stimulation. ECG,
left- and right-ventricular endocardial monophasic action potentials (MAPs) and pressures (LVP, RVP) were re-
corded. The electromechanical window (EMW; Q to LVP at 90% relaxation minus QT interval) was calculated.
LQT1 was mimicked by infusion of the KCNQ1/IKs blocker HMR1556.
Results: At baseline, LSGS and right-stellate ganglion stimulation (RSGS) caused similar heart-rate acceleration
and QT shortening. Positive inotropic and lusitropic effects were more pronounced under LSGS than RSGS. IKs
blockade prolonged QTc, triggered MAP-early afterdepolarizations (EADs) and rendered the EMW negative,
but no ventricular tachyarrhythmias occurred. Superimposed LSGS exaggerated EMW negativity and evoked
TdP in 5/9 dogs within 30 s. Preceding extrasystoles originatedmostly from the outﬂow-tracts region. TdP dete-
riorated into therapy-refractory VF in 4/5 animals. RSGS did not provoke TdP/VF.
Conclusions: In thismodel of drug-induced LQT1, LSGS readily induced TdP and VF during repolarization prolonga-
tion and MAP-EAD generation, but only if EMW turned from positive to very negative. We postulate that altered
mechano-electric coupling can exaggerate regional dispersion of refractoriness and facilitates ventricular ectopy.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Stimulation of the left (LSGS) and right stellate ganglion (RSGS) has
generalized cardiovascular (i.e., heart-rate and blood-pressure rise) and
localized myocardial effects. Marked differences in chronotropic, inotro-
pic, lusitropic, and dromotropic effects exist among species, including
humans [1,2]. LSGS mainly causes electrical activation of the left-
ventricular (LV) inferior and lateral regions, whereas RSGS modulates
predominantly the anterior sides of both ventricles [3]. Sympathetic hy-
peractivity and/or regionally dispersed sympathetic innervation impinge
on these electrophysiological properties [1], potentially exaggerating
dispersion of excitation and refractoriness. Augmented LSG activity facil-
itates triggered activity [4], shortens ventricular refractoriness [5], and
reduces the threshold for ventricular ﬁbrillation (VF) in normal and
structurally-remodeled hearts [6,7].
Sympathetic-related ventricular tachyarrhythmias are a hallmark of
the long-QT syndrome type 1 (LQT1), as arrhythmic events are mostly
evoked during exercise and/or emotion (~90% of symptomatic LQT1 pa-
tients) [8]. Accordingly, beta-adrenergic receptor blockade is the main-
stay of therapy, and left-cardiac sympathetic denervation should be
considered in symptomatic patients when beta-blockade is not effec-
tive, not tolerated or contraindicated [9–11].
Previous studies in canine LQTS models addressed the effects of uni-
lateral or bilateral stellate ganglion stimulation during cesium-chloride-
induced QT prolongation [12] and d-sotalol-induced LQT2 [13].
In drug-induced LQT1, TdP was readily evoked by the beta-adrenergic
agonist isoproterenol [14]. In the latter, exaggerated spatiotemporal dis-
persion of repolarization, substantial electromechanical heterogeneities
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(e.g., a negative electromechanical window (EMW): duration
of mechanical systole minus electrical systole) and postsystolic
aftercontractions heralded TdP, suggesting proarrhythmic contributions
of mechano-electric feedback [14]. Related to this, EMW negativity was
a strong indicator of arrhythmic risk in LQT1 patients [15].
To date, no study has addressed ventricular electromechanical rela-
tions during sympathetic-evoked arrhythmias in LQT1. We applied
LSGS and RSGS to unmask ventricular arrhythmogenic mechanisms in
the anesthetized caninemodel of drug-induced LQT1 [14]. Electrical stim-
ulation of the LSG and RSG was performed with sympathetic and vagal
nerves left intact, during an anesthetic regime with minimal inﬂuence
on beta-adrenergic responsiveness and baroreﬂex sensitivity, allowing
near-to-normal autonomic reﬂexes during sympathetic stimulation. Si-
multaneous recordings of ECGs, monophasic action potentials (MAPs)
and pressures from the left (LVP) and right ventricle (RVP) served to ex-
amine electromechanical coupling during stellate-ganglion stimulation.
2. Methods
Animal handling was in accordance with the Dutch Law on Animal Experimentation
and the EuropeanDirective for the Protection of Vertebrate Animals used for experimental
and other scientiﬁc purposes (European Union Directive 86/609/CEE). The Committee for
Experiments on Animals of Maastricht University approved the experimental protocol
(2008–116).
2.1. General
Nine adultmongrel dogs of either sex (bodyweight 32±3kg,Marshall BioResources)
were used for this study. Foodwaswithheld 12 h before the experiment. General anesthe-
sia was induced by a slow singular intravenous injection of remifentanil (0.1 μg/kg),
etomidate (0.5–1.5 mg/kg), and succinylcholine (1 mg/kg). A cuffed endotracheal tube
was inserted and connected to a respirator with 30% oxygen in pressurized air tomaintain
normocapnia, PaCO2 30–50 mm Hg. A thermal mattress was used to maintain body tem-
perature and 1.25 mL/kg/h 0.9% NaCl was administered to compensate for the periopera-
tive ﬂuid loss. Anticoagulation was achieved with 500 IU/kg unfractionated heparin.
During the experiment, anesthesia was maintained by continuous infusion of etomidate
(1.0–3.0 mg/kg/h) and remifentanil (0.6–1.0 μg/kg/min). This anesthetic regime was cho-
sen because of minimal effects on beta-adrenergic responsiveness, baroreﬂex sensitivity,
and basal hemodynamic parameters [14,16,17].
2.2. In-vivo experimental design
In all experiments standard-lead ECGs were continuously registered. Additionally,
MAP catheters (Hugo Sachs Elektronik, Harvard Bioscience, Inc.) were positioned in the
LV and RV. Endocardial MAP signalswere accepted on the basis of amplitude,morphology
and stability. Two 7F pigtail tip-micromanometer catheters (Sentron, Cordis®) were ad-
vanced via arterial and venous (femoral or carotid) access into the LV and RV cavity for
pressure recordings.
In all dogs, the left cardiac sympathetic chainwas exposed beneath the parietal pleura
by left thoracotomy between the ﬁrst and second ribs, posteriorly. In three dogs, the con-
tralateral stellate ganglion was also exposed and prepared for electrical stimulation. The
vagal nerves were left intact and sympathetic neural decentralization was not performed.
Custom-made bipolar electrodeswere used for unilateral stellate stimulations. Pulses gen-
eratedwere 2–4mA in amplitude, 2 ms in duration, 10–15 Hz in frequency [1,3,6,13], and
were maintained for 33 ± 12 s. The frequency of stimulation was chosen to mimic the
spontaneous ﬁring rate in efferent cardiac sympathetic nerves during a physiological re-
ﬂex (Online Fig. 1) [18]. If both sympathetic stellate ganglia were to be stimulated in an
experiment, the RSG was stimulated ﬁrst. The aim of our experiments was to investigate
the arrhythmogenic mechanisms during LSGS-evoked ventricular arrhythmias; RSGS
was performed only to conﬁrm known physiological responses. At least 5 min between
successive stimulations were allowed for full recovery of the nerve, and hemodynamic
and electrophysiological parameters.
Once a reproducible response to either stellate ganglion was established in at least
two consecutive stimulations, HMR1556, an IKs blocker targeting KCNQ1 [19], was admin-
istered intravenously at 25–50 μg/kg/min (mean 46 ± 10 μg/kg/min) to mimic LQT1.
HMR1556was titrated to reach maximal IKs inhibition, as assessed by stable QT prolonga-
tion N25% from baseline [14], before stellate ganglion stimulation was repeated. If TdP or
VFwas induced, electrical stimulation and HMR1556 infusionwere discontinued immedi-
ately, followed by magnesium administration and external electrical cardioversion in at-
tempts to restore sinus rhythm.
2.3. Data analysis
Electrophysiological, hemodynamic and electromechanical parameters described
below were analyzed during ten consecutive sinus-rhythm (or supraventricular) beats,
momentarily before and at maximal SGS, both under baseline conditions and during IKs
blockade.
Heart rate and QT interval were measured from an extremity lead (usually lead II)
with a discernible T-wave ending and the longest QT interval. Heart-rate corrected QT
(QTc) was calculated using van de Water's formula, QTc = QT-0.087(RR-1000), which is
superior to Bazett's in anesthetized dogs [20]. Tpeak-Tend was calculated as amarker of spa-
tial dispersion of ventricular repolarization.
LV and RVMAP durations weremeasured at 90% repolarization (MAPD90). Beat-to-beat
variability of repolarization was measured on LV and RVMAP recordings during 10 consec-
utive beats in the absence of ventricular ectopy. Short-term variability was calculated as:
STV = ∑(|MAPDn-MAPDn-1|)/(10*√2). Long-term variability as: LTV = ∑(|MAPDn
+MAPDn-1-2*MAPDmean|)/(10*√2) [21]. Also, the occurrence of early afterdepolarizations
(EADs) in MAPs, and EAD-preceding transient repolarization delays (i.e., when dVMAP/dt
turned less negative or zero) were noted.
Ventricular peak systolic and end-diastolic pressure, duration of ventricular contrac-
tion at 90% relaxation (QLVP90), and the dP/dtmax, dP/dtmin were measured. The EMW
was calculated by subtracting the QT interval from the QLVP90. The pressure signals
were carefully screened for (low-amplitude) aftercontractions [14].
If ventricular tachyarrhythmia occurred, we located the origin of the triggering pre-
mature ventricular complex (PVC) by analyzing the QRS morphology and the sequence
of RV and LVMAP activation. The last supraventricular beat before TdP/VFwas designated
beat “0” with the preceding intervals being I(−n) (Online Fig. 2). These RR intervals
were measured to determine the pause dependency of arrhythmia initiation, deﬁned as
I(−1) ≥ 150% I(−2) [22]. QT, EMW, and QLVP90 were compared between TdP-inducible
and noninducible stimulations. Dogswere designated “resistant” if no TdP/VF could be in-
duced during SGS.
2.4. Statistical analysis
Data were measured in 10 consecutive beats, using the average for further statistical
analysis. Pooled data were expressed as mean ± standard deviation. Normality was
assessed for each dataset using the Shapiro-Wilk test. Differences of parameters in paired
datawere assessed using the paired-samples t-test or theWilcoxon signed rank test as ap-
propriate. Intergroup comparisonwas performedusing the Student's t-test or the Kruskal-
Wallis test. A P value of b0.05 was considered statistically signiﬁcant.
3. Results
3.1. Stellate ganglion stimulation of the normal canine heart
Fig. 1 depicts representative examples of the cardiac effects of LSGS
and RSGS at baseline. During LSGS, heart rate increased by 79% and
the QT interval shortened by 23%, effectively reducing QTc from 290
± 24 to 253 ± 13 ms (P = 0.0003; Online Table 1). LV and RV
MAPD90 analysis did not reveal augmented interventricular or temporal
(i.e., beat-to-beat) dispersion of repolarization. In both ventricles,
inotropy increased signiﬁcantly: LV peak systolic pressure by 37% and
RVP by 157%. LV dP/dtmax increased by 394%. LV dP/dtmin decreased
by 110%, indicating increased lusitropy, and effectively leading QLVP90
to shorten from 373 ± 65 to 214 ± 46 ms (−43%, P = 0.006; Online
Table 1). Changes in diastolic LVP did not reach statistical signiﬁcance.
Due to preferentialmechanical-systole over QT shortening, LV EMWde-
creased from 95± 53 to 9 ± 42ms (P=0.009, Fig. 2). RV inotropy and
lusitropy also increased signiﬁcantly (Online Table 1).
LSGS readily evoked a junctional or low-atrial tachycardia, overrid-
ing the LSGS-induced accelerated sinus rhythmwithin 6±3 s (asterisks
in Fig. 1). Occasionally, solitary RV/LV ectopic activity occurred during
LSGS, but MAP-EADs, aftercontractions, or (non)sustained ventricular
tachyarrhythmias (NSVT) were not observed. In approximately one
third of LSG stimulations a short-lived paradoxical heart-rate slowing
was observed, which could be counteracted by atropine.
We observed an immediate and protracted (87 ± 41 s) vagal re-
bound following LSGS (Fig. 3) characterized by sinus bradycardia, ven-
tricular ectopy, and episodes of idioventricular rhythm. The post-LSGS
systolic LVP remained elevated during this vagal episode, and returned
to steady-state values parallel with the restoration of sinus rhythm.
Such vagal reboundwas never observed after isoproterenol administra-
tion in the same experimental set-up [14].
RSGS (n = 3, Fig. 1) caused comparable heart-rate accelerations
(188 ± 55 bpm) as LSGS (in the absence of decentralization), without
provoking supraventricular arrhythmias. Both QT and QTc intervals
shortened signiﬁcantly (by 29% and 18% respectively), but these were
not different from the effects of LSGS. Endocardial MAPD90 decreased
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similarly in both ventricles (Online Table 1). RSGS-evoked positive
inotropy was less prominent than during LSGS. Similarly, we observed
only limited QLVP90 shortening upon RSGS, resulting in less EMW re-
duction than upon LSGS (Online Table 1).
3.2. Repolarization instability during IKs inhibition
Intravenous administration of HMR1556 prolonged QT and QTc to
373 ± 65 and 371 ± 61 ms, respectively (+21% and + 20%; P= 0.002
and P = 0.007, Table 1). Heart rate decreased to 60 ± 11 bpm (P =
0.0003). Preferential LV over RV MAPD90 prolongation (335 ± 74 and
286±50ms; Pb 0.0001) augmented interventricular dispersion of repo-
larization. This was paralleled by a more pronounced LV temporal dis-
persion of repolarization, with STV-MAPD90 increasing by 129% and
LTV-MAPD90 by 173%. LV EADs emerged in four dogs at a wide range of
cycle lengths; RV EADs in three dogs (Fig. 4). Upon IKs inhibition, the
LV-peak systolic pressure and LV dP/dtmax increased to 114 ±
19 mm Hg (+23%; P= 0.01) and 2373 ± 1159 mm Hg/s (+27%; P =
0.001). Despite a signiﬁcant prolongation of the electrical systole,
QLVP90 remained unaltered, providing an EMW negativity of −14 ±
69 ms (P= 0.001, Fig. 2). No sizeable aftercontractions or spontaneous
ventricular arrhythmias occurred under these conditions.
3.3. Proarrhythmic proclivity of LSGS during drug-induced LQT1
Left-sided sympathetic stimulation during IKs inhibition led to QTc
and APD90 shortening to 306 ± 44 ms and 225 ± 31 ms respectively
(Table 1). A markedly decreased QLVP90 rendered the EMW negative
(−61 ± 34 ms; P= 0.0004, Fig. 2). Beat-to-beat variability of repolari-
zation duration increased and T-wave amplitudes reduced. Under these
conditions, TdP/VF occurred in 5 of 9 dogs after 26± 6 s (Fig. 5). Inmost
animals, once TdP initiated it rapidly degenerated into VF that did not
respond to immediate and repeated electrical cardioversion, and was
resistant to magnesium infusion. In one dog, a protracted vagal period
with intermittent episodes of nonsustained VT was observed after ter-
mination of VF. RSGS was never torsadogenic.
In the dogs with inducible TdP/VF, pre-LSGS QT was signiﬁcantly
more prolonged and LV EMWmore negative than in resistant animals:
440 ± 67 versus 344 ± 56 ms (P = 0.007) and −64 ± 87 versus 27
±40ms (P=0.04), respectively (Fig. 6). EMWnegativitywasmore pro-
nounced in the ﬁnal beats preceding TdP/VF (reaching−94±31ms at I
(0)), compared with the non-inducible group (−43± 25ms; P=0.002,
Figs. 5 and 6). QLVP90 did not differ between these groups. QT prolonga-
tionwasmore exaggerated (282±53ms; P=0.02) in the beats prior to
TdP when compared to pre-NSVT (225 ± 21 ms) or solitary PVCs (229
± 39 ms) in susceptible animals, and EMW was more negative −94
± 31 ms prior to TdP/VF (P = 0.005) versus −23 ± 37 ms (pre-
NSVT), and−38 ± 37 ms (pre-PVC).
An initial delay in MAP repolarization was present throughout a
broad range of RR cycle lengths during LSGS and IKs blockade, but
Fig. 1. Representative examples of effects of LSGS and RSGS on ECG, LVP, and RVP characteristics. Upon LSGS, a junctional tachycardia appeared after 6 s (*), which was interspersed by
ventricular extrasystoles. The EMW, being positive at baseline, turned negative during LSGS (−40 ms, red), but not during RSGS (89 ms, green). LSG indicates left-stellate ganglion;
RSG, right stellate ganglion; EMW, electromechanical window; LVP, left-ventricular pressure; RVP, right-ventricular pressure.
Fig. 2. Bar graph demonstrating the mean QT, QLVP, and EMW changes after LSGS,
HMR1556, and LSGS during IKs inhibition. * P b 0.05. Abbreviations as in Fig. 1.
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overt EADs did not occur (Fig. 4). Increased diastolic slopes suggesting
delayed afterdepolarizations were also not observed. During this condi-
tionwith fast-rate dependent electrical instability andmechano-electric
heterogeneity, relatively short-coupled non-pause dependent PVCs oc-
curred (Figs. 5–7). Macroscopic aftercontractions preceded TdP in one
dog. The TdP/VF-triggering PVCs typically had an intermediate QRS
axis, large QRS amplitudes, and their earliest endocardial activation at
the RV MAP signal (in 4/5 dogs, Fig. 7), suggesting focal activation in
the vicinity of the outﬂow-tracts region. In one animal, TdP initiation
emerged from the inferior LV. TdP onset was non-pause dependent
with I(−1) never exceeding I(−2). In some cases ventricular ectopy oc-
curred prior to I(−2).
Table 1
Electrophysiological and hemodynamic effects of HMR1556 and unilateral stellate ganglion stimulation.
Baseline HMR P value + LSGS P value + RSGS P value
RR interval (ms) 680 ± 116 1026 ± 168 0.0002 481 ± 184 b0.0001 407 ± 82 0.02
Heart rate (bpm) 91 ± 17 60 ± 11 0.0003 142 ± 48 b0.0001 152 ± 30 0.01
QT interval (ms) 280 ± 23 373 ± 65 0.002 260 ± 50 b0.0001 246 ± 37 0.005
QTc (ms) 308 ± 17 371 ± 61 0.007 306 ± 44 b0.0001 298 ± 34 0.003
Tp-Te (ms) 57 ± 27 92 ± 34 0.03 47 ± 16 b0.0001 44 ± 10 0.007
Left ventricle
MAPD90 (ms) 238 ± 29 335 ± 74 0.001 225 ± 31 0.001 230 ± 58 0.14
MAP-STV 2.8 ± 1.6 6.4 ± 4.6 0.003 6.1 ± 3.9 0.08 8.9 ± 11.3 0.76
MAP-LTV 3.3 ± 1.5 9.0 ± 8.1 0.02 10.2 ± 10.0 0.42 7.3 ± 9.2 0.86
LVP syst. (mm Hg) 102 ± 24 114 ± 19 0.01 180 ± 22 b0.0001 150 ± 27 0.0003
LVP diast. (mm Hg) 12 ± 8 14 ± 8 0.003 5 ± 8 0.003 16 ± 14 0.35
dP/dtmax (mm Hg/s) 1734 ± 857 2373 ± 1159 0.001 9267 ± 3498 b0.0001 3556 ± 1615 0.02
dP/dtmin (mm Hg/s) −3127 ± 2634 −4432 ± 3466 0.07 −8774 ± 7044 0.0004 −3025 ± 1063 0.04
QLVP90 (ms) 360 ± 31 355 ± 34 0.86 198 ± 77 0.0002 248 ± 45 0.002
EMW (ms) 79 ± 36 −14 ± 69 0.001 −61 ± 34 0.0004 11 ± 31 0.81
Right ventricle
MAPD90 (ms) 213 ± 21 286 ± 50 0.008 209 ± 52 b0.0001 204 ± 33 0.03
RVP syst. (mm Hg) 25 ± 9 28 ± 8 0.03 64 ± 16 0.003 35 ± 4 0.0002
RVP diast. (mm Hg) 6 ± 4 8 ± 5 0.02 7 ± 5 0.05 6 ± 6 0.03
dP/dtmax (mm Hg/s) 610 ± 316 820 ± 641 0.13 4635 ± 1526 0.005 929 ± 309 0.03
dP/dtmin (mm Hg/s) −266 ± 47 −329 ± 39 0.02 −3290 ± 4983 0.008 −483 ± 150 0.12
STV indicates short-term variability; LTV, long-termvariability;MAPD90,monophasic action potential duration at 90% repolarization; LVP, left-ventricular pressure; QLVP90, time fromQRS
onset to 90% LV pressure normalization; EMW, electromechanical window.
Fig. 3. Vagal rebound post-LSGS at baseline. Upon termination of LSGS, and during a
protracted positive inotropic response (upper panel), sinus and junctional bradycardia,
ventricular extrasystoles and idioventricular rhythm occurred, indicating a vagal
response by a baroreﬂex loop and/or sympathetic withdrawal. The lower ECG traces A,
B, C, and D are ECG examples at different stages of the vagal rebound. LVP indicates left-
ventricular pressure.
Fig. 4. Top, LV MAPs and ﬁrst derivative (dV/dt) of MAP signal. After HMR1556, EADs
followed after an initial delay in repolarization (arrowheads). Upon concomitant
LSGS at 10–15 Hz, frank EAD upstrokes were absent but a discernable delay in
repolarization (arrows) remained present, contributing to MAPD90 prolongation. Bottom,
rate dependency of MAPD90 at baseline (square), during HMR1556 (circle) and
simultaneous LSGS (triangle). Black symbols: EAD present; gray symbols: initial delay in
repolarization. LSGS indicates left-stellate ganglion stimulation; APD90, action potential
duration at 90% repolarization; CL, cycle length.
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4. Discussion
This is the ﬁrst study to demonstrate the proarrhythmic conse-
quences of LSGS in an in-vivo model of drug-induced LQT1 [14] in
which autonomic reﬂexes, neurocardiac transmission and cardiac
electromechanical coupling are only mildly inﬂuenced by the applied
anesthesia. In-vivo IKs blockade prolonged ventricular repolarization
duration and augmented spatial and temporal repolarization disper-
sion, recapitulating LQT1 aspects. Only with concomitant LSGS did TdP
occur, despite global repolarization shortening. Arrhythmia initiation
was always fast-rate (non-pause) dependent [22,23], with themajority
Fig. 5. Induction of TdP, degenerating into VF, after a short-coupled non-pause dependent
PVC during LSGS in drug-induced LQT1. Abbreviations as in Fig. 1.
Fig. 6. Top, beat-to-beat changes in RR interval, QT interval, QLVP90, and EMW during HMR1556 and LSGS just prior to TdP (left) or at 26 s and maximal chronotropic response (no TdP;
right). Pre-LSGS QT and EMWwere signiﬁcantlymore pronounced in TdP-susceptible animals. TdP initiation was fast-rate dependent due to short-coupled non-pause dependent PVCs. #
indicates P b 0.05. Below, simultaneous recording of ECG lead II and LVP to illustrate EMW variations.
Fig. 7.Outﬂow-tract origins of TdP/VF-triggering (non-pause dependent) PVC. Left, 6‑lead
ECG recording showing an intermediate QRS axis with a relatively short duration. Right,
box plot of interventricular activation delay of the junctional beats versus the TdP/VF-
triggering extrasystoles demonstrating the earliest electrical activation in the RV in all
but one case.
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of triggering beats originating in the vicinity of the outﬂow-tracts re-
gion. This is consistent with the site of TdP onset in the majority of
LQTS patients [24].
In this model of drug-induced LQT1, the ﬁnding of LSGS-induced re-
polarization shortening suggests that intense sympathetic stimulation
can enhance residual IKs despite pharmacological inhibition. Other
cesium-chloride-induced LQTS models with sympathetic stimulation
led to similar results [12,25]. Inotropic and particularly lusitropic
inﬂuences were dominant during left-sided stimulation. Therefore, me-
chanical systole shortened, and in the face of regional repolarization
prolongation by IKs inhibition alone, superimposed LSGS exaggerated
EMW disparity (Fig. 2), especially just prior to TdP. In most susceptible
dogs with drug-induced LQT1 and LSGS, TdP rapidly deteriorated into
deﬁbrillation-resistant VF. Pronounced EMW negativity related to
torsadogenesis has also been observed during beta-adrenergic stimula-
tion in experimental LQT1 [17] and in clinical studies on symptomatic
patients with genetically-conﬁrmed LQTS [15,26]. This suggests that
LSGS imposes regional electromechanical heterogeneities that facilitate
arrhythmia during IKs inhibition/loss of function. In the present experi-
ments, macroscopic aftercontractions were infrequently observed, but
we speculate that the local myocardial effects of LSGS could have pro-
duced low-amplitude aftercontractile events (below the radar of global
intracavitary pressure)with similar arrhythmogenic signiﬁcance during
EMW negativity. Future studies could focus on examining mechano-
electric triggers of arrhythmia in LQTS.
4.1. Proarrhythmic proclivity of LSGS during IKs inhibition
The present ﬁndings conﬁrm the arrhythmogenic role of left-sided
cardiac sympathetic hyperactivity in a clinically-relevant LQT1 model.
Sympathetically-induced TdP/VF was markedly resistant to deﬁbrilla-
tion attempts. Sympathetic hyperactivity, releasing norepinephrine lo-
cally at the myocardial nerve endings, accentuates heterogeneity in
ventricular repolarization under these conditions, and favors reentrant
excitation, whereas circulating catecholamines or infused (nor)epi-
nephrine act more uniformly [27]. These differences are accompanied
by a considerably larger positive inotropic (but similar chronotropic)
response upon LSGS followed by a protracted vagal rebound. This
vagal accentuation could be explained by the sudden sympathetic with-
drawal and/or by baroreﬂex activation in response to the elevated arte-
rial pressures. Supported by the observation of a prominent vagal
rebound in the rare case of successful cardioversion of VF, our results
suggest that reﬂex vagal activation may have promoted the LQT1-
related TdP to deteriorate into VF. Vagal nerve stimulation operates
mainly by antagonizing cardiac sympathetic activity, but it also in-
creases ventricular dispersion of repolarization, as demonstrated in
the setting of drug-induced LQT2 [28]. Moreover, when applied during
induced VF in pigs or sheep, vagal nerve stimulation increases the
variability of the dominant VF frequency, potentially sustaining the
arrhythmia [29].
The triggers for life-threatening events in most LQT1 patients are
either physical (75%) or emotional stress (15%) while rest/sleep ac-
counts for only 10% [8]. One third of patients have events during
swimming [8]. These arrhythmias are effectively prevented in most
LQT1 patients by beta-blockade or by left-cardiac sympathetic de-
nervation [9,30]. On the other hand, strong vagal reﬂexes have
been implicated in high-risk LQT1 patients [31,32], and cold-water
submersion and swimming, a genotype-speciﬁc trigger, provokes
powerful co-stimulation of both sympathetic and parasympathetic
limbs, at least in the ﬁrst instances [33]. Our experimental results
do not allow ﬁrm conclusions on the contribution of vagal stimula-
tion to ventricular proarrhythmia in LQTS, but they lend indirect
support to the concept of “autonomic conﬂict” [34], which indicates
that a more convoluted vago-sympathetic interaction can facilitate
ventricular tachyarrhythmia.
4.2. Limitations
The present study involved a relatively small number of animals,
which was driven by ethical considerations. However, the differences
in results obtained in paired analysis or group comparisonswere so pro-
found that they readily reached statistical signiﬁcance.
The use of an anesthesia model always brings into question the car-
diovascular and autonomic effects of anesthesia, especially when deal-
ing with autonomic interventions. In the present study, we minimized
potentially confounding effects [16,17] by the choice of anesthetics.
5. Conclusions
For the ﬁrst time in an in-vivomodel of drug-induced LQT1, we dem-
onstrate the arrhythmogenic potency of LSGS to induce TdP and VF dur-
ing repolarization prolongation, MAP-EADs generation, exaggerated
spatiotemporal dispersion of repolarization, and EMW negativity. LSGS
always rendered the EMWmore negative prior to arrhythmia induction,
which suggests that altered mechano-electric coupling is somehow in-
volved in the proarrhythmic proclivity. Triggering PVCs most often
emerged from the LV and RV outﬂow-tract regions. Our results offer
novel mechanistic understanding of LQT1-related arrhythmogenesis
and strengthen the rationale for left-cardiac sympathetic denervation
in the prevention of life-threatening arrhythmias in several cardiac dis-
orders, ranging from channelopathies [10] to structural heart diseases
[10,11].
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